Stocks
Allogene Therapeutics (ALLO) EPS US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EPS, rub | ? | -1.34 | -2.38 | -2.09 | -1.32 | -0.87 | -0.72 | ||
| Changes by years, y/y, % | -31% | +77% | -12% | -37% | -35% | -14.9% | |||
Allogene Therapeutics. EPS, rub
Allogene Therapeutics. EPS, changes, %
Allogene Therapeutics (ALLO) EPS US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EPS, rub | ? | -0.28 | -0.23 | -0.19 | -0.18 | -0.18 | -0.72 | |
| Changes by years, y/y, % | -28% | -33% | -41% | -38% | -36% | |||
| Changes by quarters, q/q, % | -3% | -16% | -20% | -6% | +1% | |||
